Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uetake

Showing results (31-40 of 206) with videos related to

Pageof 21
Sort By:
EJVES Short Reports|March 1, 2019
Assessment of the Severity of Ischaemia and the Outcomes of Revascularisation in Peripheral Arterial Disease Patients Based on the Skin Microcirculatory Response to a Thermal Load TestYohei Yamamoto, Yoshinori Inoue, Kimihiro Igari, et al.
International Journal of Cancer|September 24, 2004
JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model studyHirotoshi Kobayashi, Tsuyoshi Gonda, Hiroyuki Uetake, et al.
Annals of Surgical Oncology|August 10, 2007
Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinomaYanislav Kolev, Hiroyuki Uetake, Satoru Iida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[A case of sigmoid colon cancer with synchronous multiple liver and lung metastases, who survived 25-month after combination of chemotherapy and metastasectomy]Akifumi Kikuchi, Toshiaki Ishikawa, Hiroyuki Uetake, et al.
Current Oncology (Toronto, Ont.)|October 22, 2021
Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal <i>MET</i> Amplification from Aneuploidy in Diverse Advanced CancersYuichi Kumaki, Steve Olsen, Mitsukuni Suenaga, et al.
Clinics and Practice|March 22, 2022
Nuclear Expression of p-STAT3 Is Associated with Poor Prognosis in ER(-) Breast CancerTsuyoshi Nakagawa, Goshi Oda, Hiroshi Kawachi, et al.
Cancers|July 25, 2019
Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable OncogenesOtília Menyhart, Tatsuhiko Kakisaka, Lőrinc Sándor Pongor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancerLabile Togba Soumaoro, Hiroyuki Uetake, Tetsuro Higuchi, et al.
Clinical Colorectal Cancer|October 28, 2017
Clinical Features of Regorafenib-induced Liver Injury in Japanese Patients From Postmarketing ExperienceHiroyuki Uetake, Kenichi Sugihara, Kei Muro, et al.
Anticancer Research|March 16, 2016
Genome-wide DNA Copy-number Analysis in ACTS-CC Trial of Adjuvant Chemotherapy for Stage III Colonic CancerToshiaki Ishikawa, Hiroyuki Uetake, Kenta Murotani, et al.
Pageof 21

Showing results (31-40 of 206) with videos related to

Sort By:
Pageof 21
EJVES Short Reports|March 1, 2019
Assessment of the Severity of Ischaemia and the Outcomes of Revascularisation in Peripheral Arterial Disease Patients Based on the Skin Microcirculatory Response to a Thermal Load TestYohei Yamamoto, Yoshinori Inoue, Kimihiro Igari, et al.
International Journal of Cancer|September 24, 2004
JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model studyHirotoshi Kobayashi, Tsuyoshi Gonda, Hiroyuki Uetake, et al.
Annals of Surgical Oncology|August 10, 2007
Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinomaYanislav Kolev, Hiroyuki Uetake, Satoru Iida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[A case of sigmoid colon cancer with synchronous multiple liver and lung metastases, who survived 25-month after combination of chemotherapy and metastasectomy]Akifumi Kikuchi, Toshiaki Ishikawa, Hiroyuki Uetake, et al.
Current Oncology (Toronto, Ont.)|October 22, 2021
Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal <i>MET</i> Amplification from Aneuploidy in Diverse Advanced CancersYuichi Kumaki, Steve Olsen, Mitsukuni Suenaga, et al.
Clinics and Practice|March 22, 2022
Nuclear Expression of p-STAT3 Is Associated with Poor Prognosis in ER(-) Breast CancerTsuyoshi Nakagawa, Goshi Oda, Hiroshi Kawachi, et al.
Cancers|July 25, 2019
Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable OncogenesOtília Menyhart, Tatsuhiko Kakisaka, Lőrinc Sándor Pongor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancerLabile Togba Soumaoro, Hiroyuki Uetake, Tetsuro Higuchi, et al.
Clinical Colorectal Cancer|October 28, 2017
Clinical Features of Regorafenib-induced Liver Injury in Japanese Patients From Postmarketing ExperienceHiroyuki Uetake, Kenichi Sugihara, Kei Muro, et al.
Anticancer Research|March 16, 2016
Genome-wide DNA Copy-number Analysis in ACTS-CC Trial of Adjuvant Chemotherapy for Stage III Colonic CancerToshiaki Ishikawa, Hiroyuki Uetake, Kenta Murotani, et al.
Pageof 21